文献速递肝病消化道肿瘤与早癌

丙型肝炎病毒诱导的肿瘤起始性癌症干细胞样细胞在异种移植肿瘤模型中激活基质成纤维细胞

Hepatitis C virus-induced tumor-initiating cancer stem-like cells activate stromal fibroblasts in a xenograft tumor model.
PubMed 文献 · Hepatology · 2017-10-30

本研究探讨丙型肝炎病毒(HCV)诱导的肿瘤起始性癌症干细胞样细胞植入小鼠后是否激活基质成纤维细胞。结果显示异种移植肿瘤中多种成纤维细胞活化标志物(包括基质金属蛋白酶2)在mRNA或蛋白水平显著升高,且小鼠来源的成纤维细胞活化标志物在肿瘤中特异性增加;HCV感染肝细胞条件培养基可激活肝星状细胞纤维化相关标志物,且这些细胞表达转化生长因子β;抗转化生长因子β中和抗体可抑制原代人肝星状细胞的纤维化标志物活化。结论认为HCV感染肝细胞通过分泌转化生长因子β诱导局部成纤维细胞活化。

要点

  • HCV诱导的肿瘤起始性癌症干细胞样细胞异种移植后肿瘤中成纤维细胞活化标志物显著升高。
  • HCV感染肝细胞条件培养基可激活肝星状细胞纤维化相关标志物。
  • 抗转化生长因子β中和抗体可抑制HCV感染肝细胞条件培养基诱导的原代人肝星状细胞纤维化标志物活化。

核心结论

  • HCV感染肝细胞通过分泌转化生长因子β诱导局部成纤维细胞活化,且肝细胞的癌前或肿瘤状态影响肿瘤相关成纤维细胞环境的网络。

研究设计与样本

  • 研究将HCV诱导的肿瘤起始性癌症干细胞样细胞植入小鼠,观察异种移植肿瘤中成纤维细胞活化标志物的变化,并体外用HCV感染肝细胞条件培养基处理肝星状细胞。

主要发现

  • 异种移植肿瘤中多种成纤维细胞活化标志物(包括基质金属蛋白酶2)在mRNA或蛋白水平显著增加。
  • 肿瘤中小鼠来源的成纤维细胞活化标志物特异性增加,提示成纤维细胞迁移形成基质。
  • HCV感染肝细胞条件培养基激活肝星状细胞中纤维化相关标志物。
  • HCV感染肝细胞表达转化生长因子β,可激活基质成纤维细胞标志物。
  • 抗转化生长因子β中和抗体与HCV感染肝细胞条件培养基共孵育时,抑制原代人肝星状细胞的纤维化标志物活化。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Hepatitis C virus (HCV) often causes persistent infection and is an increasingly important factor in the etiology of fibrosis/cirrhosis and hepatocellular carcinoma, although the mechanisms for the disease processes remain unclear. We have shown previously that HCV infection generates an epithelial-mesenchymal transition state and tumor-initiating cancer stem-like cells in human hepatocytes. In this study, we investigated whether HCV-induced tumor-initiating cancer stem-like cells when implanted into mice activate stromal fibroblasts. A number of fibroblast activation markers, including matrix metalloproteinase 2, were significantly increased at the mRNA or protein level in the xenograft tumors, suggesting the presence of tumor-associated fibroblasts. Fibroblast activation markers of murine origin were specifically increased in tumor, suggesting that fibroblasts migrate to form stroma. Next, we demonstrated that conditioned medium from HCV-infected human hepatocytes activates fibrosis-related markers in hepatic stellate cells. We further observed that these HCV-infected hepatocytes express transforming growth factor beta, which activates stromal fibroblast markers. Subsequent analysis suggested that anti-transforming growth factor beta neutralizing antibody, when incubated with conditioned medium from HCV-infected hepatocytes, inhibits fibrosis marker activation in primary human hepatic stellate cells. CONCLUSION: HCV-infected hepatocytes induce local fibroblast activation by secretion of transforming growth factor beta, and a preneoplastic or tumor state of the hepatocytes influences the network for the tumor-associated fibroblast environment. (Hepatology 2017;66:1766-1778).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Sasaki R, Devhare P, Ray RB, et al. Hepatitis C virus-induced tumor-initiating cancer stem-like cells activate stromal fibroblasts in a xenograft tumor model. Hepatology. 2017. PMID: 28664988. doi:10.1002/hep.29346

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。